302 related articles for article (PubMed ID: 28694016)
1. [
Criswell SR; Nielsen SS; Warden M; Perlmutter JS; Moerlein SM; Flores HP; Huang J; Sheppard L; Seixas N; Checkoway H; Racette BA
Neurotoxicology; 2018 Jan; 64():43-49. PubMed ID: 28694016
[TBL] [Abstract][Full Text] [Related]
2. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
Criswell SR; Perlmutter JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
Neurology; 2011 Apr; 76(15):1296-301. PubMed ID: 21471467
[TBL] [Abstract][Full Text] [Related]
3. MRI Signal Intensity and Parkinsonism in Manganese-Exposed Workers.
Criswell SR; Nielsen SS; Warden MN; Flores HP; Lenox-Krug J; Racette S; Sheppard L; Checkoway H; Racette BA
J Occup Environ Med; 2019 Aug; 61(8):641-645. PubMed ID: 31348423
[TBL] [Abstract][Full Text] [Related]
4. Selective D2 receptor PET in manganese-exposed workers.
Criswell SR; Warden MN; Searles Nielsen S; Perlmutter JS; Moerlein SM; Sheppard L; Lenox-Krug J; Checkoway H; Racette BA
Neurology; 2018 Sep; 91(11):e1022-e1030. PubMed ID: 30097475
[TBL] [Abstract][Full Text] [Related]
5. A screening tool to detect clinical manganese neurotoxicity.
Racette BA; Gross A; Criswell SR; Checkoway H; Searles Nielsen S
Neurotoxicology; 2018 Jan; 64():12-18. PubMed ID: 28274800
[TBL] [Abstract][Full Text] [Related]
6. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
Brenner SR
Neurology; 2011 Nov; 77(20):e120; author reply e120. PubMed ID: 22084283
[No Abstract] [Full Text] [Related]
7. Pathophysiology of manganese-associated neurotoxicity.
Racette BA; Aschner M; Guilarte TR; Dydak U; Criswell SR; Zheng W
Neurotoxicology; 2012 Aug; 33(4):881-6. PubMed ID: 22202748
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent progression of parkinsonism in manganese-exposed welders.
Racette BA; Searles Nielsen S; Criswell SR; Sheppard L; Seixas N; Warden MN; Checkoway H
Neurology; 2017 Jan; 88(4):344-351. PubMed ID: 28031394
[TBL] [Abstract][Full Text] [Related]
9. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
Criswell SR; Perlmutter JS; Crippin JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
Arch Neurol; 2012 Mar; 69(3):394-7. PubMed ID: 22410448
[TBL] [Abstract][Full Text] [Related]
10. Screening for early detection of parkinsonism using a self-administered questionnaire: a cross-sectional epidemiologic study.
Lundin JI; Checkoway H; Criswell SR; Hobson AJ; Harris RC; Swisher LM; Evanoff BA; Racette BA
Neurotoxicology; 2014 Dec; 45():232-7. PubMed ID: 24035927
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of parkinsonism associated with welding exposure.
Racette BA; Criswell SR; Lundin JI; Hobson A; Seixas N; Kotzbauer PT; Evanoff BA; Perlmutter JS; Zhang J; Sheppard L; Checkoway H
Neurotoxicology; 2012 Oct; 33(5):1356-61. PubMed ID: 22975422
[TBL] [Abstract][Full Text] [Related]
12. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.
Bowler RM; Roels HA; Nakagawa S; Drezgic M; Diamond E; Park R; Koller W; Bowler RP; Mergler D; Bouchard M; Smith D; Gwiazda R; Doty RL
Occup Environ Med; 2007 Mar; 64(3):167-77. PubMed ID: 17018581
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation and white matter alterations in occupational manganese exposure assessed by diffusion basis spectrum imaging.
Criswell SR; Nielsen SS; Faust IM; Shimony JS; White RL; Lenox-Krug J; Racette BA
Neurotoxicology; 2023 Jul; 97():25-33. PubMed ID: 37127223
[TBL] [Abstract][Full Text] [Related]
14. Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders.
Stormezand GN; Chaves LT; Vállez García D; Doorduin J; De Jong BM; Leenders KL; Kremer BPH; Dierckx RAJO
Neuroimage Clin; 2020; 25():102161. PubMed ID: 31981888
[TBL] [Abstract][Full Text] [Related]
15. Manganese exposure, parkinsonian signs, and quality of life in South African mine workers.
Dlamini WW; Nelson G; Nielsen SS; Racette BA
Am J Ind Med; 2020 Jan; 63(1):36-43. PubMed ID: 31647574
[TBL] [Abstract][Full Text] [Related]
16. Thalamic GABA levels and occupational manganese neurotoxicity: Association with exposure levels and brain MRI.
Ma RE; Ward EJ; Yeh CL; Snyder S; Long Z; Gokalp Yavuz F; Zauber SE; Dydak U
Neurotoxicology; 2018 Jan; 64():30-42. PubMed ID: 28873337
[TBL] [Abstract][Full Text] [Related]
17. Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees.
Baker MG; Criswell SR; Racette BA; Simpson CD; Sheppard L; Checkoway H; Seixas NS
Scand J Work Environ Health; 2015 Jan; 41(1):94-101. PubMed ID: 25380186
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders.
Searles Nielsen S; Checkoway H; Criswell SR; Farin FM; Stapleton PL; Sheppard L; Racette BA
Parkinsonism Relat Disord; 2015 Apr; 21(4):355-60. PubMed ID: 25634431
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic utility of positron emission tomography for parkinsonism after chronic manganese exposure].
Abe Y; Kachi T; Kato T; Ito K; Yanagisawa N; Sobue G
Rinsho Shinkeigaku; 1999 Jul; 39(7):693-9. PubMed ID: 10548904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
